SANTA ANA, Calif., May 24 /PRNewswire/ -- Well-noted medical industry
visionaries will soon be gathering together for Medical Data International's
third annual Biomaterials of the Future Conference and Exhibition, taking
place on June 14-15 at the Grand Hyatt San Francisco on Union Square in
San Francisco, Calif.
Biomaterials, natural or synthetic substances that posses the capacity to
interact with living human tissue, are revolutionizing the medical technology
marketplace. While many traditional medical technologies are anticipated to
have marginal growth rates in today's managed care driven environment,
biomaterials product markets are forecast to experience phenomenal growth.
Well-informed healthcare executives of traditional medical technologies have
already begun to invest in emerging biomaterials products, in the belief that
these products will eventually replace existing ones.
The event serves as an annual business forum for senior healthcare
executives and investors to hear the latest developments and opportunities in
biomaterials and tissue engineering technology from preeminent researchers,
clinicians, suppliers and academicians. In addition to the industry synopsis
provided, presentations from 24 emerging biomaterials technology companies
looking for funding, partnerships and alliances will also provide the audience
with an opportunity to thoroughly explore how biomaterials are being adapted
into today's most promising products and technologies.
Key presentations will be made by well-noted industry authorities,
including: Robert Langer, Sc.D., Kenneth J. Germeshausen, Professor of
Chemical and Biomedical Engineering, Massachusetts Institute of Technology;
A. Hari Reddi, Ph.D., Professor and Ellison Chair, Musculoskeletal Molecular
Biology, Center for Tissue Regeneration & Repair, University of California,
Davis Medical Center; David J. Mooney, Ph.D., Department of Chemical
Engineering, University of Michigan; Eugene P. Goldberg, Ph.D., Director,
Biomaterials Center, University of Florida; James M. Anderson, M.D., Ph.D.,
Professor of Pathology, Macromolecular Science and Biomedical Engineering,
Case Western Reserve University; William D. Spotnitz, M.D., Professor of
Thoracic and Cardiovascular Surgery, Director Tissue Adhesive Center,
University of Virginia Health Sciences Center; Gregory R. Evans, M.D., FACS,
Associate Professor, University of Texas, Anderson Cancer Center;
Jennifer L. West, Ph.D., T.N., Law Assistant Professor, Department of
Bioengineering, Rice University.
Companies presenting their products and technologies include: Advanced
Materials Design, LLC, developers of new combinatorial methods for biomaterial
design & synthesis; Anika Therapeutics, Inc. producers of hyaluronic acid;
Battelle Pacific NW Research, manufacturers of biomaterials for use in tissue
repair and drug delivery; BIOSYNTECH Limited, developers of biopolymer based
delivery systems; Chrysalis Biotechnology, Inc., makers of synthetic thrombin
peptide; CytoTherapeutics, Inc., developers of cell-based therapeutics;
Desmos, Inc., manufacturers of biocoatings for medical devices; Encelle, Inc.,
creators of implantable bioartificial organs; ETEX Corporation, producers of
bone tissue repair products; FibroGen, Inc., developers of recombinant
collagen and synthetic gelatin; Fusion Medical Technologies, manufacturers of
biomaterials for bleeding control; Harvest Technologies Inc., developers of
autologous glues and sealants; Implant Sciences Corporation, manufacturers of
radioactive products for cancer therapy and cardiovascular applications;
Interpore Cross International, producers of synthetic bone graft material,
autologous growth factors & spinal implants; Islet Sheet Medical, makers of a
thin-sheet bio-artificial pancreas; Islet Technology, Inc., developers of
encapsulated pancreatic islets for transplantation; Molecular Geodesics, Inc.,
developers of biomimetic materials for tissue engineering; MTF Innovations,
makers of allograft bone and soft tissue; Tutogen Medical, Inc., creators of
biomaterials for use in tissue repair and reconstruction; and USBiomaterials,
developers of surface active biomaterials.
Co-sponsors of the event include: Battelle, The Patterson Group, Medmarc
and The Hartford, The Society for Biomaterials and PR Newswire.
Medical Data International, an IHS Group Company, is a business knowledge
company serving the medical technology and managed care segments of the
worldwide healthcare industry. MDI's products and services include
proprietary consulting, procedure and managed care databases, conferences,
monthly and daily newsletters, plus frequently updated market and technology
reports.
To learn more about this and other MDI conferences, visit Medical Data
International's Web site at http://www.medicaldata.com/conferences/bio99 or call an
account manager at 800-826-5759. For media inquiries, contact Abida Baig at
714-800-1102.
Registration Information
The two-day conference registration fee is $1,295. For press
registrations or additional information, call 800-826-5759 or visit the web
site at http://www.medicaldata.com
SOURCE Medical Data International
 back to top
Related links:
http://www.medicaldata.com/conferences/bio99
CONTACT:
Abida Baig of Medical Data International,
714-800-1102
|
